Regulatory Approval

A deep dive into REX American's stellar earnings reveals a new playbook for the ethanol industry, where government incentives and carbon capture are the new keys to success.

A landmark decision by Medicare provides reimbursement for Bayesian Health's AI sepsis tool, accelerating the fight against a leading cause of hospital deaths.

A new wave of at-home neuromodulation devices is dismantling old treatment paradigms. We explore the shift from clinic to living room and what it means for patients and investors.

By cutting federal red tape, the Colusa Indian Community is accelerating a multi-million dollar energy and AI agenda, forging a new model for tribal power.

Israeli firm Medibyt's FDA-cleared AI platform, CPETWise, slashes diagnostic time by over 50%, promising to make complex heart and lung tests more accessible.

Adicet Bio nears a pivotal data readout for its lupus CAR-T, now viable for outpatient use, while launching a novel solid tumor attack in prostate cancer.

Fujirebio's new Health Canada-approved assays promise a new era for brain health diagnostics, but questions of patient access and cost loom large.

A new all-season road promises freedom for a remote First Nation and unlocks a mineral treasure trove. But does this blueprint for progress ignore deeper costs?

With its new COVID vaccine approved, Novavax is leveraging global partners like Sanofi to earn royalties, proving an asset-light model can rival industry giants.

After a strategic reset, Australian biopharma Immuron reports record sales and a stronger cash position, pivoting to partner its high-value drug candidates.

A new FDA approval for Roche's HER2 tests paves the way for a powerful new drug, offering hope to patients with aggressive gastroesophageal adenocarcinoma.

Indiana Michigan Power is cutting rates by $59M, saving families $100 a year. The real story? A surge in data centers is footing the bill. A look at the new energy math.

Surf Air Mobility's OperatorOS gets the FAA's blessing, moving regional aviation from paper binders to screens and positioning the company as a tech vendor.

Blykalla's second advanced reactor application in Tierp signals Sweden's strategic pivot to nuclear, leveraging innovative SMR tech to meet ambitious energy goals.

As Boeing celebrates record sales, a string of scrapped jets, rejected deliveries, and silenced whistleblowers reveals a disturbing gap between its financial recovery and manufacturing reality.

The strategic acquisition combines engineered probiotics with CRISPR-based technology, creating a powerful new toolkit to revolutionize livestock health.

As the EU's strict new packaging laws loom, a Shanghai lab offers a vital lifeline for Asia-Pacific exporters, turning a complex compliance hurdle into an innovation race.

Merlin's new design authority from New Zealand isn't just a certificate; it's a strategic move that could reshape the path to commercial autonomous flight.

FDA clearance for Roche's pTau217 blood test isn't just a clinical win; it's a strategic move to dominate a $27B market by making diagnosis simple and scalable.

Takeda's ORZEYFUL, a first-in-class orexin agonist, wins approval in Japan, offering the first treatment for the root cause of Narcolepsy Type 1.